Piperidines as chemokine modulators (CCR)

Details Piperidines as chemokine modulators (CCR) Piperidines as chemokine modulators (CCR)

2011-06-07

2011-06-07

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S249000, C514S269000, C514S307000, C514S318000, C514S323000, C546S141000, C546S193000, C546S201000, C546S209000, C546S210000

Reexamination Certificate

active

07956070

ABSTRACT:
Compounds of formula (I):are modulators of chemokine (for example CCR3) activity (for use in, for example, treating asthma).

REFERENCES:
patent: 5935974 (1999-08-01), Rae et al.
patent: 6124319 (2000-09-01), MacCoss et al.
patent: 6140349 (2000-10-01), Caldwell et al.
patent: 6166037 (2000-12-01), Budhu et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6358979 (2002-03-01), Finke et al.
patent: 6444686 (2002-09-01), Ko et al.
patent: 6489354 (2002-12-01), Bao et al.
patent: 6566376 (2003-05-01), Baxter et al.
patent: 6605623 (2003-08-01), Ko et al.
patent: 6627629 (2003-09-01), Ko et al.
patent: 7265227 (2007-09-01), Evans et al.
patent: 7709500 (2010-05-01), Alcaraz et al.
patent: 2005/0107428 (2005-05-01), Alcaraz et al.
patent: 2007/0054924 (2007-03-01), Alcaraz et al.
patent: 2008/0108661 (2008-05-01), Cage et al.
patent: 0903349 (1999-03-01), None
patent: WO9710207 (1997-03-01), None
patent: WO9723458 (1997-07-01), None
patent: WO9818761 (1998-05-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO0012478 (2000-03-01), None
patent: WO0029377 (2000-05-01), None
patent: WO 00/31033 (2000-06-01), None
patent: WO0035449 (2000-06-01), None
patent: WO0035451 (2000-06-01), None
patent: WO0035452 (2000-06-01), None
patent: WO0035453 (2000-06-01), None
patent: WO0035454 (2000-06-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO0102381 (2001-01-01), None
patent: WO 01/62728 (2001-08-01), None
patent: WO 01/62729 (2001-08-01), None
patent: WO0162757 (2001-08-01), None
patent: WO0177101 (2001-10-01), None
patent: WO0198269 (2001-12-01), None
patent: WO0198270 (2001-12-01), None
patent: WO 02/20484 (2002-03-01), None
patent: WO 02/30899 (2002-04-01), None
patent: WO 02/039125 (2002-05-01), None
patent: WO0250070 (2002-06-01), None
patent: WO 03/018556 (2003-03-01), None
patent: WO 03/068743 (2003-08-01), None
patent: WO 03/082190 (2003-10-01), None
patent: WO 2005/073192 (2005-08-01), None
patent: WO2007/114770 (2007-10-01), None
Rollins “Chemokines” Blood, v.90(3)p. 909-928 (1997).
Cohen et al. “Cytokine function . . . ” CA 125:31527 (1996).
Braga et al. “Making crystals . . . ” J. Royal. soc. Chem. Chem. Commun. p. 3635-3645 (2005).
Kenner et al. “acylation of . . . ” CA50:8632 (1956).
Kensende “Hydrogen bonding and . . . ” CA96:34416 (1982).
Boskabady et al. “The effect of exposure . . . ” Pathophysiology v.14, p. 97-104 (2007).
Barnes, “Cytokine-directed therapies for the treatment of chronic airway diseases”,Cytokine&Growth Factor Reviews14:511-522 (2003).
Boskabady and Kiani, “The Effect of Exposure of Guinea Pig to Cigarette Smoke and their Sensitization in Tracheal Responsiveness to Histamine and Histamine Receptor (H1) Blockade by Chlorpheniramine”,Pathophysiology14:97-104 (2007).
Cohen et al., “Cytokine function: A study in biologic diversity”,CAPLUS125:31527 (1996).
King, “Bioisosteres, Conformational Restriction, and Pro-drugs—Case History: An Example of a Conformational Restriction Approach”,Medicinal Chemistry: Principles and Practicepp. 206-209 (1994).
Patani et al., “Bioisosterism: A Rational Approach in Drug Design”,Chem. Rev. 96:3147-3148, 3170 (1996).
Rollins, “Chemokines”,Blood90(3):909-928 (1997).
Hodgson et al., “Chemokines and Drug Discovery”,Drug News Perspect17(5):335-338 (2004).
Baggiolini, M., “Chemokines in pathology and medicine”,Journal of Internal Medicine250:91-104 (2001).
Gould, “Salt selection for basic drugs”,International Journal of Pharmaceutics33:201-217 (1986).
USPTO Non-Final Office Action in U.S. Appl. No. 11/866,611, mailed Jun. 15, 2009, 25 pages.
International Search Report.

Affiliated with

Also associated with

Rating

Piperidines as chemokine modulators (CCR) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidines as chemokine modulators (CCR), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidines as chemokine modulators (CCR) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2621220